WHAT IT IS TRYING TO CHANGE
What the project is doing
PEARL rapamycin longevity study is being developed as part of the wider effort to prevent, delay or repair age-related decline.
What this could do for you
If the effect in people is large enough, this could become a medicine used to slow one or more processes that drive age-related decline.
What has to happen next
The next checkpoint is whether the treatment is safe enough and shows enough biological activity to continue.
What could stop it
The study is mainly about safety and dose. It may not show whether people actually live longer or feel better.